Share this article:
Link, Azamian

Link, Azamian

Irvine-based Tarsus Pharmaceuticals, which is backed by Orange County’s best-known ophthalmology venture capital executive, Bill Link, and several other notable area investors, has raised $60 million to continue testing a drug that aims to be the first of its type to treat a common disease affecting the eye...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to OCBJ.com archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99

For reprint and licensing requests for this article, Contact Kim Lopez